NVAX trade ideas
NVAX Ready to Break? Novavax
Short Term - We look to Sell at 66.01 (stop at 72.46)
Trades with a bearish descending triangle formation. Trading volume is increasing. We look for losses to be extended today. A close below the key support at 68.00 is expected to lead to further selling pressure. Closed below the 20-day EMA.
Our profit targets will be 40.74 and 38.59
Resistance: 68.00 / 100.00 / 120.00
Support: 50.00 / 40.0 / 30.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
New update for Novavax (elliot waves)Follow up here. If my count is correct (which is until now), we shall see a move higher and complete the primary corrective waves of WXY, which it seems to be the A wave from the corrective ABC waves after the big drop from 230. After that I expect a B corrective wave and then the C and the end of the corrective wave and hopefully the breakout from the lows.
Nvax analysisI can't find any bull case (just yet) on technicals. Although, there are few targets for bears here. It seems that we have a bear flag and Abcde move. The e wave, which is form from ABC wave, has 3 possible targets according to fib levels, all inside in the flag... We are touching the 1st at close. (sometimes the e wave is shorter)
If we have a break down next week, there are 2 targets. 1st the bear flag pole (64$). Which is exactly at last fib level of the possible wave C within the X wave. Also touching a trendline there. So it is a very high probability to stop there.
2nd the SHS pattern. That's the worst case for longs, because it can take us down to 58. The good thing with it is that, there is the demand area which can do very strong reversal move imo.
Good luck to all
NVAX - Capitulation move might be nextDoomscalling can be fun at the ATH when valuations are through the roof, but are most overlooked when price seems enticing, should be higher *because it was so high earlier*. But that's when the price is the most vulnerable.
From what I see on the 3 Day chart, flag breakdown is in progress.
Downside target is 54, which should find good support.
Be careful if you are long.
Chaos Reigns Hah... These trend lines are the accumulation of attempts to figure this thing out over the last year. Ridiculous price action but learned to leverage the volatility and play the extremes.
Currently at a relative downside extreme. Also signs of Wyckoff Accumulation similar to the build up when it popped Jan 2021.
Time series 1-month point forecast target is 163, NVAX price action is cyclical so these forecasts are more difficult than when there is merely trend/seasonality.
Technical levels I’m looking for to the upside are 111-120, 146, 180. Catalysts are here so it’s now or never I guess and calls are relatively cheap.
Not financial advice.
Novavax Breaking Out? Novavax - Short Term - We look to Buy at 83.80 (stop at 75.92)
Price action has posted a bullish Engulfing Candle and is positive for short-term sentiment. We look for gains to be extended today. Short term oscillators have turned positive. Although the bears are in control, the stalling negative momentum indicates a turnaround is possible.
Our profit targets will be 101.48 and 112.00
Resistance: 90.00 / 100.00 / 140.00
Support: 70.00 / 60.00 / 50.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
Nvax One to watch on Monday. Breakout of downtrendinf resiatnce. Backtesting and flagging on previous resiatnce as new suppor targeting 95 to 120 max
New update for NovavaxMy Elliott wave count for NVAX. I expect a re-accumulation and a visit at the low 60s maybe will touch 50s before going up again.
NVAX: Covid Stocks to Move Lower? Novavax - Short Term - We look to Sell at 69.18 (stop at 77.64)
Trades with a bearish descending triangle formation. A break of bespoke support at 70.00, and the move lower is already underway. We look for losses to be extended today. We look to set shorts in early trade for a further test of the fragile looking support. Closed below the 20-day EMA.
Our profit targets will be 47.66 and 38.59
Resistance: 86.00 / 100.00 / 120.00
Support: 70.00 / 60.00 / 50.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
Novavax head and shoulders patternTaking a long position for the potential head and shoulders pattern.
Novavax do or die (short term) - Updated chart Very interesting to see what will happen on Monday (ER call). Rising wedge as well... most probably we will follow the channel and finish wave 5 at around 65$.
Novavax and elliott wave (short term) Novavax will complete primary wave 2, which is an ABC correction. In my opinion we will visit again 60s in order to complete the wave 5 within wave C prior the new wave up.
NVAX - Taking a short possitionTaking a short-term short position here expecting to revisit the low 70s. Also hidden divergence in stochastic.
NOVAVAX - Wyckoff accumulation and Elliott waves (UPDATE)After following the price action the last couple of months, it is now so obvious that we are in a Wyckoff accumulation. I look now for a shakeout event to happen on the next following dates, which will test the supply/demand balance in the low 60s, before the back-up.
Updated chartThis is an updated chart to include new price action and the impulsive wave 5 structure. The target remains the same.
Novavax new Elliott wave is startingNASDAQ:NVAX According to Elliott's waves theory, we finished a cycle from $230 to $85, plus an extension to $66. Now we have started a new cycle, which, I assume is until the bottom of wave 4 of the downtrend cycle at max. My target will be between $110 to 126$.
Then we will start a corrective wave structure ABC until wave 4 at about $90.
covid vaccine maker trying daily higher low (NVAX)novavax blew up after announcing it was making a covid vaccine. they eventually parléd this into a montly uptrend that lasted until september '21. since then it has seen a major decline. the stock is attempting to end that now, or at least find a temporary rally from new multi year lows. this could lead to a short squeeze zipping the price back up towards weekly highs targeting around 94-97
Novavax coming down to 2 interesting levelsWill place low risk pos. in these areas with tight stops.
Pt´s around the local low´s
Novavax long - mid-term bullish until earnings Feb 28thPlease reference my previous post on the weekly.
It appears we have just a little more time to close in the yellow triangle on the weekly.
This chart demonstrates the daily time frame. Last time RSI was this low there was a rally of 100$.
I expect that there may be more touch of the major support level and then reversal with uptrend.
Place stop loss at ~70 -75$ or the long-term triangle idea is invalid
red line = 200 week EMA (slope of the most recent few weeks of input)
green line = 50 week EMA (slope of the most recent few weeks of input)
not financial advice
NovavaxDown to the True Jenkins line. See if it bounce off it. (Michael S Jenkins. Square root out of bottom price +2 then resquare! Draw the trend line from bottom to the number you get at exactly one year later. )
Novavax: Selloff Incoming? Novavax - Intraday - We look to Sell at 110.96 (stop at 127.66)
Previous support level of 120.00 broken. Daily signals are bearish. We look for losses to be extended today. The bias is still for lower levels and we look for any gains to be limited.
Our profit targets will be 77.28 and 55.00
Resistance: 120.00 / 140.00 / 150.00
Support: 110.00 / 80.00 / 50.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
